Home NDC 0186-6040-01 NEXIUM
Product NDC 0186-6040
Requested package NDC 0186-6040-01
11-digit product format 001866040
Labeler code 0186
Product ID 0186-6040_24d37125-c3cf-48e0-9e50-75cbc818e7c1
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name Esomeprazole sodium
Dosage form INJECTION
Route INTRAVENOUS
Labeler AstraZeneca Pharmaceuticals LP
Application NDA021689
Marketing category NDA
Marketing start 2005-05-03
Marketing end 0000-00-00
Substance ESOMEPRAZOLE SODIUM
Active strength 40 mg/5mL
Pharmacologic classes Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]
NDC exclude flag No
Listing certified through 2023-12-31
Current FDA listing Historical FDA.report record Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 9 matching rows.
View current auxiliary records. · View the auxiliary file history.
Captured / source date, Snapshot, Source SHA-256 table Captured / source date Snapshot Source SHA-256 2025-12-14 17:58 UTC · source 2025-12-05 d630ba8d3edf…732f749b63fb…2025-08-27 00:01 UTC · source 2025-08-26 f5e01cc5f278…a2eaf40c39c3…2025-04-01 02:39 UTC · source 2025-03-31 2ef7874e63bc…57b86245f4fa…2025-03-28 20:22 UTC · source 2025-03-28 a1b67e2a42f9…c4cf2c586c0d…2025-03-22 03:12 UTC · source 2025-03-21 cfe11265f3b6…090c488252e2…2025-03-10 12:48 UTC · source 2025-03-10 cdf11ea48f46…ba0047e9e063…2025-02-02 03:52 UTC · source 2025-01-31 302b2466d912…e7b80fea0513…2025-01-20 13:05 UTC · source 2025-01-20 ed331223b511…672a5bd82f5f…2025-01-11 03:41 UTC · source 2025-01-10 0efc9e666f02…f202fb6c5f17…
Source provenance: Browse the complete Orange Book source catalog · source snapshot 1 .
Orange Book products# Current product rows page 1 of 1 · 2 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N021689-001 NEXIUM IV ESOMEPRAZOLE SODIUM EQ 20MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** INJECTABLE / INTRAVENOUS RLD 2005-03-31 N021689-002 NEXIUM IV ESOMEPRAZOLE SODIUM EQ 40MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** INJECTABLE / INTRAVENOUS RLD 2005-03-31
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 3 · 82 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-02-19 14:30 UTC 2026-02 N021689-001 NEXIUM IV EQ 20MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** INJECTABLE / INTRAVENOUS RLD 2005-03-31 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N021689-002 NEXIUM IV EQ 40MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** INJECTABLE / INTRAVENOUS RLD 2005-03-31 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N021689-001 NEXIUM IV EQ 20MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** INJECTABLE / INTRAVENOUS RLD 2005-03-31 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N021689-002 NEXIUM IV EQ 40MG BASE/VIAL INJECTABLE / INTRAVENOUS RLD 2005-03-31 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N021689-001 NEXIUM IV EQ 20MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** INJECTABLE / INTRAVENOUS RLD 2005-03-31 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N021689-002 NEXIUM IV EQ 40MG BASE/VIAL INJECTABLE / INTRAVENOUS RLD 2005-03-31 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N021689-001 NEXIUM IV EQ 20MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** INJECTABLE / INTRAVENOUS RLD 2005-03-31 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N021689-002 NEXIUM IV EQ 40MG BASE/VIAL INJECTABLE / INTRAVENOUS RLD 2005-03-31 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N021689-001 NEXIUM IV EQ 20MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** INJECTABLE / INTRAVENOUS RLD 2005-03-31 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N021689-002 NEXIUM IV EQ 40MG BASE/VIAL INJECTABLE / INTRAVENOUS RLD 2005-03-31 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N021689-001 NEXIUM IV EQ 20MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** INJECTABLE / INTRAVENOUS RLD 2005-03-31 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N021689-002 NEXIUM IV EQ 40MG BASE/VIAL INJECTABLE / INTRAVENOUS RLD 2005-03-31 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N021689-001 NEXIUM IV EQ 20MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** INJECTABLE / INTRAVENOUS RLD 2005-03-31 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N021689-002 NEXIUM IV EQ 40MG BASE/VIAL INJECTABLE / INTRAVENOUS RLD 2005-03-31 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N021689-001 NEXIUM IV EQ 20MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** INJECTABLE / INTRAVENOUS RLD 2005-03-31 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N021689-002 NEXIUM IV EQ 40MG BASE/VIAL INJECTABLE / INTRAVENOUS RLD 2005-03-31 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N021689-001 NEXIUM IV EQ 20MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** INJECTABLE / INTRAVENOUS RLD 2005-03-31 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N021689-002 NEXIUM IV EQ 40MG BASE/VIAL INJECTABLE / INTRAVENOUS RLD 2005-03-31 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 N021689-001 NEXIUM IV EQ 20MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** INJECTABLE / INTRAVENOUS RLD 2005-03-31 d06236e962d9…2024-10-29 15:01 UTC 2024-10 N021689-002 NEXIUM IV EQ 40MG BASE/VIAL INJECTABLE / INTRAVENOUS RLD 2005-03-31 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N021689-001 NEXIUM IV EQ 20MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** INJECTABLE / INTRAVENOUS RLD 2005-03-31 79d66fd596c7…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N021689-002 NEXIUM IV EQ 40MG BASE/VIAL INJECTABLE / INTRAVENOUS AP RLD, RS 2005-03-31 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N021689-001 NEXIUM IV EQ 20MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** INJECTABLE / INTRAVENOUS RLD 2005-03-31 301d65b070ca…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N021689-002 NEXIUM IV EQ 40MG BASE/VIAL INJECTABLE / INTRAVENOUS AP RLD, RS 2005-03-31 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N021689-001 NEXIUM IV EQ 20MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** INJECTABLE / INTRAVENOUS RLD 2005-03-31 1e350fbaab3a…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N021689-002 NEXIUM IV EQ 40MG BASE/VIAL INJECTABLE / INTRAVENOUS AP RLD, RS 2005-03-31 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 N021689-001 NEXIUM IV EQ 20MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** INJECTABLE / INTRAVENOUS RLD 2005-03-31 8072bd15b7f6…2024-05-31 18:47 UTC 2024-05 N021689-002 NEXIUM IV EQ 40MG BASE/VIAL INJECTABLE / INTRAVENOUS AP RLD, RS 2005-03-31 8072bd15b7f6…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 N021689-001 NEXIUM IV EQ 20MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** INJECTABLE / INTRAVENOUS RLD 2005-03-31 5c6f7cd8ea54…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 N021689-002 NEXIUM IV EQ 40MG BASE/VIAL INJECTABLE / INTRAVENOUS AP RLD, RS 2005-03-31 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 N021689-001 NEXIUM IV EQ 20MG BASE/VIAL INJECTABLE / INTRAVENOUS RLD 2005-03-31 5d02ea3f76ae…2022-04-08 23:34 UTC 2022-04 N021689-002 NEXIUM IV EQ 40MG BASE/VIAL INJECTABLE / INTRAVENOUS AP RLD, RS 2005-03-31 5d02ea3f76ae…2022-04-04 05:41 UTC 2022-04 N021689-001 NEXIUM IV EQ 20MG BASE/VIAL INJECTABLE / INTRAVENOUS RLD 2005-03-31 4b0b4de00fa7…2022-04-04 05:41 UTC 2022-04 N021689-002 NEXIUM IV EQ 40MG BASE/VIAL INJECTABLE / INTRAVENOUS AP RLD, RS 2005-03-31 4b0b4de00fa7…2019-12-13 00:20 UTC 2019-12 N021689-001 NEXIUM IV EQ 20MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** INJECTABLE / INTRAVENOUS RLD 2005-03-31 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N021689-002 NEXIUM IV EQ 40MG BASE/VIAL INJECTABLE / INTRAVENOUS AP RLD, RS 2005-03-31 74a2ff9319b5…2022-03-09 01:35 UTC 2022-03 N021689-001 NEXIUM IV EQ 20MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** INJECTABLE / INTRAVENOUS RLD 2005-03-31 bb7c543d1eb4…2022-03-09 01:35 UTC 2022-03 N021689-002 NEXIUM IV EQ 40MG BASE/VIAL INJECTABLE / INTRAVENOUS AP RLD, RS 2005-03-31 bb7c543d1eb4…2021-12-28 21:50 UTC 2021-12 N021689-001 NEXIUM IV EQ 20MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** INJECTABLE / INTRAVENOUS RLD 2005-03-31 782e0a99824c…2021-12-28 21:50 UTC 2021-12 N021689-002 NEXIUM IV EQ 40MG BASE/VIAL INJECTABLE / INTRAVENOUS AP RLD, RS 2005-03-31 782e0a99824c…
Observed Orange Book normalized TE history# DailyMed Socrata Ingredients# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Marketing end Sample Exclude flag Status 0186-6040-01 00186604001 10 VIAL in 1 CARTON (0186-6040-01) > 5 mL in 1 VIAL 10 vial 2005-05-03 0000-00-00 No No Current